Skip to main content
. 2015 Oct 31;6(12):1209–1214. doi: 10.1021/acsmedchemlett.5b00359

Figure 5.

Figure 5

Development of tolerance to antiallodynic effect, measured by the von Frey test (A) and antihyperalgesic effect measured by the cold plate test (B) after repeated once daily (6 days) i.t. injections of morphine (M, 3.5 nmol), hybrid compounds 12 (0.8 nmol) and 13 (1 nmol), and the NK1 parent compound 5 (2.3 nmol); *p < 0.05, **p < 0.01, ***p < 0.001 vs Veh-treated CCI-exposed rats; #p < 0.05, ##p < 0.01 vs morphine-treated CCI-exposed rats.